Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)

Bibliographic Details
Main Authors:	Wamil, M, Coleman, RL, Adler, A, McMurray, JJ, Holman, RR
Format:	Conference item
Language:	English
Published:	American Diabetes Association 2020

Similar Items

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
by: Wamil, M, et al.
Published: (2021)

Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model
by: Coleman, RL, et al.
Published: (2019)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
by: Coleman, R, et al.
Published: (2005)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
by: Adler, A, et al.
Published: (2003)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
by: Matthews, DR, et al.
Published: (1998)

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47).
by: Adler, A, et al.
Published: (1999)

Ethnic differences in diabetic nephropathy - The UKPDS
by: Stevens, R, et al.
Published: (1999)

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
by: Turner, R, et al.
Published: (1998)

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
by: Davis, T, et al.
Published: (2013)

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
by: Adler, A, et al.
Published: (2005)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
by: Matthews, DR, et al.
Published: (1998)

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
by: Stevens, R, et al.
Published: (2001)

Historical HbA1c values may explain the type 2 diabetes legacy effect: UKPDS 88
by: Lind, M, et al.
Published: (2021)

Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)
by: Adler, AI, et al.
Published: (2024)

Risk of heart failure in type 2 diabetes
by: Coleman, R, et al.
Published: (2003)

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.
by: Davis, T, et al.
Published: (1999)

UKPDS: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects
by: Widjaja, A, et al.
Published: (1996)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
by: Cull, C, et al.
Published: (1995)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
by: Holman, R, et al.
Published: (2001)

Forecasting coronary case fatality in type 2 diabetes: a UKPDS Risk Engine equation
by: Stevens, R, et al.
Published: (2002)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
by: Clarke, P, et al.
Published: (2004)

UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.
by: Widjaja, A, et al.
Published: (1997)

Effect of Valsartan on the Incidence of Diabetes REPLY
by: Holman, R, et al.
Published: (2010)

Risk factors for incident albuminuria and renal dysfunction in the UKPDS
by: Adler, A, et al.
Published: (2000)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
by: Turner, R, et al.
Published: (1999)

The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study.
by: Matthews, DR
Published: (1999)

The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study.
by: Matthews, DR
Published: (1999)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
by: Wamil, M, et al.
Published: (2020)

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).
by: Clarke, P, et al.
Published: (2003)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
by: Cull, C, et al.
Published: (2001)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
by: Cull, C, et al.
Published: (2000)

UKPDS: what was the question? UK Prospective Diabetes Study.
by: Turner, R, et al.
Published: (1999)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
by: Holman, R
Published: (2007)

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
by: Kothari, V, et al.
Published: (2002)

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
by: Stevens, R, et al.
Published: (2004)

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
by: Alva, M, et al.
Published: (2014)

Estimating risk of clinically evident neuropathy in Type 2 diabetes: a UKPDS risk equation
by: Coleman, R, et al.
Published: (2006)

Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
by: Coleman, R, et al.
Published: (2007)

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.
by: McMurray, J, et al.
Published: (2014)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
by: Cull, C, et al.
Published: (2004)